This constant state of inflammation is not without consequencesit has been shown to: Worsen autoimmune conditions, such as rheumatoid arthritis , lupus , and multiple sclerosis and others
Most individuals notice weight and fat changes in 12 to 16 weeks
So if youre on GLP-1 or considering it, please remember: The goal is not to become smaller
For post-GLP-1 patients with mild to moderate skin laxity particularly in the face, neck, abdomen, and arms RF microneedling offers a meaningful improvement without surgical incisions
Regulatory Timeline (According to FDA Announcements): October 2, 2024: FDA indicated tirzepatide shortage resolved (later superseded) December 19, 2024: FDA issued a declaratory order reaffirming shortage resolution February 18, 2025: 503A enforcement discretion ended March 19, 2025: 503B enforcement discretion ended Industry Context: Some reporting has described ongoing disputes about how certain compounded tirzepatide formulations are marketed following shortage-related enforcement discretion changes
Results vary based on individual goals
.png)
